Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release
Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release
Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press ReleaseSee all News
Paul FreimanVenture Partner, Brazil
Over 40 years of experience in founding and management of biotechnology and healthcare companies. Mr. Freiman, former CEO of Syntex, led the company through its acquisition by Roche Holdings in $5.3 billion transaction. He has been chairman of the Pharmaceutical Manufacturers of America Association (PhRMA) and has also chaired a number of key PhRMA committees both domestic and international. He served as CEO of a biotech firm based in California. He serves on three biotechnology Boards as well as that of a Major Japanese Company.
Currently domiciled in Rio de Janeiro, Mr. Freiman has extensive experience in Latin America, having also served as Vice President Latin America.